MeiraGTx Holdings (MGTX) EBIT Margin Growth (1y) (2020 - 2025)

MeiraGTx Holdings (MGTX) EBIT Margin Growth (1y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 78.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1,049.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,238.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -10,520.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1,651.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,002.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,091.00
10 MeiraGTx Holdings 1.10 Bn 1.03 Bn - 17,142.00

Historic Data

Download Data
DateValue
Dec 31, 2025 17,142.00
Sep 30, 2025 -1.09 Mn
Jun 30, 2025 1.62 Mn
Dec 31, 2024 -60,212.00
Sep 30, 2024 28,152.00
Jun 30, 2024 -1.64 Mn
Mar 31, 2024 -575,786.00
Dec 31, 2023 -32,148.00
Sep 30, 2023 -16,843.00
Jun 30, 2023 -59,232.00
Mar 31, 2023 -44,251.00
Dec 31, 2022 81,292.00
Sep 30, 2022 -14,901.00
Jun 30, 2022 17,955.00
Mar 31, 2022 -3,062.00
Dec 31, 2021 31,240.00
Sep 30, 2021 -15,903.00
Jun 30, 2021 61,923.00
Mar 31, 2021 -10,705.00
Dec 31, 2020 -27,054.00